These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19962564)

  • 41. Extra-pulmonary features in COPD patients entering rehabilitation after stratification for MRC dyspnea grade.
    Spruit MA; Pennings HJ; Janssen PP; Does JD; Scroyen S; Akkermans MA; Mostert R; Wouters EF
    Respir Med; 2007 Dec; 101(12):2454-63. PubMed ID: 17765532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD].
    Ozgur ES; Atis S; Kanik A
    Tuberk Toraks; 2008; 56(3):296-303. PubMed ID: 18932031
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
    Kömüs N; Tertemiz KC; Sevinç C
    Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Consequences of physical inactivity in chronic obstructive pulmonary disease.
    Hartman JE; Boezen HM; de Greef MH; Bossenbroek L; ten Hacken NH
    Expert Rev Respir Med; 2010 Dec; 4(6):735-45. PubMed ID: 21128749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of the prefrontal cortex is associated with exertional dyspnea in chronic obstructive pulmonary disease.
    Higashimoto Y; Honda N; Yamagata T; Matsuoka T; Maeda K; Satoh R; Nishiyama O; Sano H; Iwanaga T; Miyara T; Muraki M; Tomita K; Kume H; Miyai I; Tohda Y; Fukuda K
    Respiration; 2011; 82(6):492-500. PubMed ID: 21474913
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mini nutritional assessment, body composition, and hospitalisations in patients with chronic obstructive pulmonary disease.
    Benedik B; Farkas J; Kosnik M; Kadivec S; Lainscak M
    Respir Med; 2011 Oct; 105 Suppl 1():S38-43. PubMed ID: 22015084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.
    Casanova C; de Torres JP; Aguirre-Jaíme A; Pinto-Plata V; Marin JM; Cordoba E; Baz R; Cote C; Celli BR
    Am J Respir Crit Care Med; 2011 Nov; 184(9):1015-21. PubMed ID: 21836135
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sex differences in mortality in patients with COPD.
    de Torres JP; Cote CG; López MV; Casanova C; Díaz O; Marin JM; Pinto-Plata V; de Oca MM; Nekach H; Dordelly LJ; Aguirre-Jaime A; Celli BR
    Eur Respir J; 2009 Mar; 33(3):528-35. PubMed ID: 19047315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The clinical utility of the GOLD classification of COPD disease severity in pulmonary rehabilitation.
    Huijsmans RJ; de Haan A; ten Hacken NN; Straver RV; van't Hul AJ
    Respir Med; 2008 Jan; 102(1):162-71. PubMed ID: 17881207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Symptoms and natural history of COPD: role of the distal airways].
    Chaouat A; Chabot F; Dusser D
    Rev Mal Respir; 2011 Oct; 28(8):1071-8. PubMed ID: 22099412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The ADO index as a predictor of two-year mortality in general practice-based chronic obstructive pulmonary disease cohorts.
    Abu Hussein N; Ter Riet G; Schoenenberger L; Bridevaux PO; Chhajed PN; Fitting JW; Geiser T; Jochmann A; Joos Zellweger L; Kohler M; Maier S; Miedinger D; Schafroth Török S; Scherr A; Siebeling L; Thurnheer R; Tamm M; Puhan MA; Leuppi JD
    Respiration; 2014; 88(3):208-14. PubMed ID: 25115178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [To breathe with COPD].
    Marín JM
    Arch Bronconeumol; 2009 Oct; 45(10):478-80. PubMed ID: 19729236
    [No Abstract]   [Full Text] [Related]  

  • 53. Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index.
    Medinas Amorós M; Mas-Tous C; Renom-Sotorra F; Rubí-Ponseti M; Centeno-Flores MJ; Gorriz-Dolz MT
    Chron Respir Dis; 2009; 6(2):75-80. PubMed ID: 19411567
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between daily living activities (ADL) limitation and the BODE index in patients with chronic obstructive pulmonary disease.
    Simon KM; Carpes MF; Corrêa KS; dos Santos K; Karloh M; Mayer AF
    Rev Bras Fisioter; 2011; 15(3):212-8. PubMed ID: 21829985
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of continuous positive airway pressure on stair-climbing performance in severe COPD patients.
    Walterspacher S; Walker DJ; Kabitz HJ; Windisch W; Dreher M
    COPD; 2013 Apr; 10(2):193-9. PubMed ID: 23547631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The BODE index as a predictor of unfavourable prognosis in chronic obstructive pulmonary disease (by the results of a prospective study)].
    Karoli NA; Rebrov AP
    Ter Arkh; 2007; 79(3):11-4. PubMed ID: 17526187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The modified BODE index: validation with mortality in COPD.
    Cote CG; Pinto-Plata VM; Marin JM; Nekach H; Dordelly LJ; Celli BR
    Eur Respir J; 2008 Nov; 32(5):1269-74. PubMed ID: 18579541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abnormal heart rate recovery and chronotropic incompetence on exercise in chronic obstructive pulmonary disease.
    Gupta M; Bansal V; Chhabra SK
    Chron Respir Dis; 2013 Aug; 10(3):117-26. PubMed ID: 23785062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors associated with prognosis in COPD: influence of body composition and systemic corticosteroid use on morbidity and mortality.
    Creutzberg EC
    Chron Respir Dis; 2004; 1(2):79-81. PubMed ID: 16279262
    [No Abstract]   [Full Text] [Related]  

  • 60. Physical Activity in Chronic Obstructive Pulmonary Disease. An Update.
    Garcia-Aymerich J
    Arch Bronconeumol; 2017 Aug; 53(8):413-414. PubMed ID: 28043729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.